Biotechs such as Gilead (NASDAQ:GILD) and Vertex Pharma (NASDAQ:VRTX), with a high local tax bill, a heavy U.S.-based ...

Pliant Therapeutics, based in South San Francisco, is laying off 45% of its workers in an attempt to extend its runway as it ...

IO Biotech's first-in-class vaccine performs double duty, killing cancer cells and enhancing the tumor microenvironment. A ...

Amid a reckoning for the gene therapy field, Vertex Pharmaceuticals has joined a growing list of companies paring back their ...

Newgarden recently invited members of the public at the South By Southwest conference and festival in Austin to experience a ...

A researcher initiated coverage of the stock with a buy recommendation. On Thursday, an analyst launched coverage of Edgewise ...

US stocks (DJI, IXIC, GSPC) ended Friday's trading session strong: the Dow Jones kept the momentum on its win streak and ...

UC Davis celebrated the formal inauguration of Aggie Square, a $1.1 billion innovation district that merges scientific ...

Opening a new chapter in the University of California, Davis’ role as a regional engine of innovation and economic growth, ...

The U.S. Food and Drug Administration is asking some of its recently fired staff responsible for critically important funding ...

Republican Vivek Ramaswamy will visit PowerFlo Solutions in Reno on Monday evening as part of his bid to become Ohio’s next ...

We think the stake in wide-moat Sartorius contributes to Bio-Rad’s moat. Although Bio-Rad does not have a controlling stake, Sartorius accounts for approximately 40% of Bio-Rad’s fair value in our ...